HSP70 Copurifies with Zika Virus Particles

Virology. 2018 Sep:522:228-233. doi: 10.1016/j.virol.2018.07.009. Epub 2018 Jul 25.

Abstract

Zika virus (ZIKV) has been identified as a cause of neurologic diseases in infants and Guillain-Barré Syndrome, and currently, no therapeutics or vaccines are approved. In this study, we sought to identify potential host proteins interacting with ZIKV particles to gain better insights into viral infectivity. Viral particles were purified through density-gradient centrifugation and subsequently, size-exclusion chromatography (SEC). Mass spectrometric analyses revealed viral envelope protein and HSP70 to comigrate in only one SEC fraction. Neither of these proteins were found in any other SEC fractions. We then performed neutralization assays and found that incubating viral particles with antibody against HSP70 indeed significantly reduced viral infectivity, while HSC70 antibody did not. Preincubating cells with recombinant HSP70 also decreased viral infectivity. Knockdown and inhibition of HSP70 also significantly diminished viral production. These results implicate HSP70 in the pathogenesis of ZIKV and identify HSP70 as a potential host therapeutic target against ZIKV infection.

Keywords: Heat shock proteins HSP70 HSC70 Zika virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Centrifugation, Density Gradient
  • Chromatography, Gel
  • HSP70 Heat-Shock Proteins / isolation & purification*
  • Host-Pathogen Interactions*
  • Humans
  • Mass Spectrometry
  • Virion / isolation & purification*
  • Zika Virus / isolation & purification*

Substances

  • HSP70 Heat-Shock Proteins